OTC Markets OTCQB - Delayed Quote USD
Bioxytran, Inc. (BIXT)
0.1350
-0.0017
(-1.24%)
At close: June 5 at 8:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
1,966.7510
2,231.0180
3,808.4970
2,440.1850
4,214.4340
Operating Income
-1,966.7510
-2,231.0180
-3,808.4970
-2,440.1850
-4,214.4340
Net Non Operating Interest Income Expense
-774.4200
-770.3610
-541.8280
-526.3210
-313.6080
Other Income Expense
-418.6230
621.3740
-212.4580
300
--
Pretax Income
-3,159.7940
-2,380.0050
-4,562.7830
-2,666.5060
-4,528.0420
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-3,159.7940
-2,366.6810
-4,472.5250
-2,473.1340
-4,031.7450
Diluted NI Available to Com Stockholders
-3,159.7940
-2,366.6810
-4,472.5250
-2,473.1340
-4,031.7450
Basic EPS
-0.04
-0.02
-0.03
-0.02
-0.04
Diluted EPS
-0.04
-0.02
-0.03
-0.02
-0.04
Basic Average Shares
119,946.2590
138,598.6910
133,973.3520
112,712.3050
106,252.1160
Diluted Average Shares
119,946.2590
138,598.6910
133,973.3520
112,712.3050
106,252.1160
Total Operating Income as Reported
-1,958.9810
-2,223.0680
-3,800.2120
-2,436.5410
-4,214.4340
Total Expenses
1,966.7510
2,231.0180
3,808.4970
2,440.1850
4,214.4340
Net Income from Continuing & Discontinued Operation
-3,159.7940
-2,366.6810
-4,472.5250
-2,473.1340
-4,031.7450
Normalized Income
-2,741.1710
-2,988.0550
-4,260.0670
-2,473.1340
-4,031.7450
Interest Expense
774.4200
770.3610
541.8280
526.3210
313.6080
Net Interest Income
-774.4200
-770.3610
-541.8280
-526.3210
-313.6080
EBIT
-2,385.3740
-1,609.6440
-4,020.9550
-2,140.1850
-4,214.4340
EBITDA
-2,377.6040
-1,601.6940
-4,012.6700
-2,136.5410
-4,214.4340
Reconciled Depreciation
7.7700
7.9500
8.2850
3.6440
0
Net Income from Continuing Operation Net Minority Interest
-3,159.7940
-2,366.6810
-4,472.5250
-2,473.1340
-4,031.7450
Total Unusual Items Excluding Goodwill
-418.6230
621.3740
-212.4580
0
--
Total Unusual Items
-418.6230
621.3740
-212.4580
0
--
Normalized EBITDA
-1,958.9810
-2,223.0680
-3,800.2120
-2,136.5410
-4,214.4340
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 1/5/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BSYI BioSyntech, Inc.
0.0000
0.00%
QRON Qrons Inc.
0.0733
0.00%
ENBI.CN Entheon Biomedical Corp.
0.1150
+15.00%
COOL.CN Core One Labs Inc.
0.1450
0.00%
RMTG Regenerative Medical Technology Group Inc.
0.0254
0.00%
AGTX Agentix Corp.
0.0320
-20.00%
SQZB SQZ Biotechnologies Company
0.0280
-6.67%
ZEOX Zeo ScientifiX, Inc.
1.9600
-0.51%
DTC.CN Defence Therapeutics Inc.
0.8200
+5.13%
RVX.TO Resverlogix Corp.
0.0400
0.00%